Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function

Endocrinology

Volumn 138, Issue 8, 1997, Pages 3476-3485

  Karanth, Sharada ^a   Linthorst, Astrid C E ^a   Stalla, Günther K ^a   Barden, Nicholas ^b   Holsboer, Florian ^a   Reul, Johannes M H M ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GLUCOCORTICOID;

ADENOHYPOPHYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; FEEDBACK SYSTEM; HORMONAL REGULATION; HYPOPHYSIS ADRENAL SYSTEM; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0030787592     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.8.5331     Document Type: Article

References (66)

1. Keller-Wood ME, Dallman MF 1984 Corticosteroid inhibition of ACTH secretion. Endocr Rev 5:1-24
2. Antoni FA 1986 Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin releasing factor. Endocr Rev 7:351-378
3. Dallman MF, Akana SF, Cascio CS, Darlington DN, Jacobson L, Levin N1987 Regulation of ACTH secretion: variations on a theme of B. Recent Prog Horm Res 43:113-173
4. De Kloet ER, Reul JMHM 1987 Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinol 12:83-105
5. Reul JMHM, De Kloet ER 1985 Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117:2505-2512
6. Reul JMHM, De Kloet ER, Van Sluijs FJ, Rijnberk A, Rothuizen J 1990 Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary. Endocrinology 127:907-915
7. McEwen BS, De Kloet ER, Rostene W 1986 Adrenal steroid receptors and actions in the nervous system. Physiol Rev 66:1121-1188
8. Gerlach JL, McEwen BS 1972 Rat brain binds adrenal steroid hormone: radioautography of hippocampus with corticosterone. Science 175:1133-1136
9. Reul JMHM, De Kloet ER 1986 Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vitro autoradiography and computerized image analysis. J Steroid Biochem 24:269-272
10. Herman JP, Patel PD, Akil H, Watson SJ 1989 Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat. Mol Endocrinol 3:1886-1894
11. Van Eekelen JAM, Jiang W, De Kloet ER, Bohn MC 1988 Distribution of the mineralocorticoid and the glucocorticoid receptor mRNAs in the rat hippocampus. J Neurosci Res 21:88-94
12. Moguilewsky M, Raynaud JP 1980 Evidence for a specific mineralocorticoid receptor in rat pituitary and brain. J Steroid Biochem 12:309-314
13. De Nicola AF, Tornello S, Weisenberg L, Fridman O, Birmingham MK 1981 Uptake and binding of [3H]aldosterone by the anterior pituitary and brain regions in adrenalectomized rats. Horm Metab Res 13:103-106
14. Krozowski Z, Funder JW 1981 Mineralocorticoid receptors in rat anterior pituitary: toward a redefinition of "mineralocorticoid hormone$. Endocrinology 109:1221-1224
15. De Kloet ER, McEwen BS 1976 A putative glucocorticoid receptor and a transcortin-like macromolecule in pituitary cytosol. Biochim Biophys Acta 421:115-123
16. Rees HD, Stumpf WE, Sar M, Petrusz P 1977 Autoradiographic studies of 3H-dexamethasone uptake by immunocytochemically characterized cells of the rat pituitary. Cell Tissue Res 182:347-356
17. Holsboer F 1995 Neuroendocrinology of affective disorders. In: Bloom F, Kupfer D (eds) Neuropsychopharmacology: Fourth Generation of Progress. Raven Press, New York pp 957-69
18. Holsboer F, Barden N 1996 Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 17:187-205
19. Holsboer F, Liebl R, Hofschuster E 1982 Repeated dexamethasone suppression test during depressive illness: normalization of test result compared with clinical improvement. J Affect Disorders 4:93-101
20. Greden JF, Gardner R, King D, Grunhaus L, Carroll BJ, Kronfol Z 1983 Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility. Arch Gen Psychiatry 40:493-500
21. Holsboer-Trachsler E, Stohler R, Hatzinger M 1991 Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression. Psychiatry Res 38:163-171
22. Reul JMHM, Stec I, Söder M, Holsboer F 1993 Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology 133:312-320
23. Reul JMHM, Labeur MS, Grigoriadis DE, De Souza EB, Holsboer F 1994 Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology 60:509-519
24. Brady LS, Whitfield Jr. HJ, Fox RJ, Gold PW, Herkenham M 1991 Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. J Clin Invest 87:831-837
25. Montkowski A, Barden N, Wotjak C, Stec I, Ganster J, Meaney M, Engelmann M, Reul JMHM, Landgraf R, Holsboer F 1995 Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function. J Neuroendocrinol 7:841-845
26. Pepin MC, Pothier F, Barden N 1992 Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature 355:725-728
27. 26a. Barden N, Stec ISM, Montkowski A, Holsboer F, Reul JMHM, Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor. Neuroendocrinology, in press
28. Gill MK, Karanth S, Dutt A, Juneja HS 1985 Effect of castration and steroid treatment on the release of gonadotropins by the rat pituitary hypothalamic complex. Horm Metab Res 17:141-146
29. Dutt A, Gill MK, Karanth S, Lehri N, Juneja HS 1986 The choice of a model for studying the hypothalamus pituitary interactions invitro. Mol Cell Endocrinol 45:21-26
30. Reul JMHM, Stec I, Wiegers GJ, Labeur MS, Linthorst ACE, Arzt E, Holsboer F 1994 Prenatal immune challenge alters the hypothalamic-pituitary-adrenocortical axis in adult rats. J Clin Invest 93:2600-2607
31. Karanth S, Lyson K, Mc Cann SM 1993 Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. Proc Natl Acad Sci USA 90:3383-3387
32. Robbins R, Reichlin S 1982 In vitro systems for the study of secretion and synthesis of hypothalamic peptides. In: Müller EE, MacLeod RM (eds) Neuroendocrine Perspectives. Elsevier Biomedical Press, Amsterdam, pp 111-135
33. Pepin MC, Pothier F, Barden N 1993 Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mol Pharmacol 42:991-995
34. Buckingham JC, Cooper TA 1984 Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine. Neuroendocrinol 38:411-417
35. Martinez-Pinerc MG, Milanes MV, Alcaraz C, Vargas ML 1994 Catecholaminergic mediation of morphine-induced activation of pituitary-adrenocortical axis in the rat: implication of alpha- and beta-adrenoceptors. Brain Res 668:122-128
36. Grossman A, Gaillard RC, McCartney P, Rees LH, Besser GM 1982 Opiate modulation of the pituitary-adrenal axis: effects of stress and circadian rhythm. Clin Endocrinol 17:279-286
37. Rittmaster RS, Cutler Jr GB, Sobel DO, Goldstein DS, Koppelman MC, Loriaux DL, Chrousos GP 1985 Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects. J Clin Endocrinol Metab 60:891-895
38. Plotsky PM 1986 Opioid inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation of rats. Regul Pept 16:235-242
39. Degli Uberti EC, Salvadori S, Trasforini G, Margutti A, Ambrosio MR, Rossi R, Portaluppi F, Pansini R 1992 Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man. J Clin Endocrinol Metab 75:370-374
40. Tsagarakis S, Navara P, Rees LH, Besser M, Grossman A 1989 Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus invitro. Endocrinology 124:2330-2335
41. Calogero AE, Galluchi WT, Gold PW, Chrousos GP 1988 Multiple feedback regulation loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications. J Clin Invest 82:767-774
42. King MS, Baertschi AJ 1989 Physiological concentrations of atrial natriuretic factors with intact N-terminal sequences inhibit corticotropin-releasing factor-stimulated adrenocorticotropin secretion from cultured anterior pituitary cells. Endocrinology 124:286-292
43. Kellner M, Herzog L, Holsboer F, Wiedemann K 1995 Circadian changes in the sensitivity of the corticotropin-releasing hormone-stimulated HPA system after arginine vasopressin and atrial natriuretic hormone in human male controls. Psychoneuroendocrinology 20:515-524
44. Saper CB, Standaert DG, Currie MG, Schwartz D, Geller DM, Needleman P 1985 Atriopeptin-immunoreactive neurons in the brain: presence in cardiovascular regulatory areas. Science 227:1047-1049
45. Jacobowitz DM, Skofitsch G, Keiser HR, Eskay RL, Zamir N 1985 Evidence for the existence of atrial natriuretic factor-containing neurons in the rat brain. Neuroendocrinology 40:92-94
46. Kawata M, Nakao K, Morii N, Kiso Y, Yamashita H, Imura H, Sano Y 1985 Atrial natriuretic polypeptide: topographical distribution in the rat brain by radioimmunoassay and immunohistochemistry. Neuroscience 16:521-546
47. Zamir N, Skofitsch G, Eskay RL, Jacobowitz DM 1986 Distribution of immunoreactive atrial natriuretic peptides in the central nervous system of the rat. Brain Res 365:105-111
48. Lim AT, Sheward J, Copolov DJ, Windmill D, Fink G 1990 Atrial natriuretic factor is released into hypophyseal portal blood: direct evidence that ANF may be a neurohormone. J Neuroendocrinology 2:15-18
49. Vermes I, Mulder GH, Smelik PG 1977 A superfusion system technique for the study of the sites of action of glucocorticoids in the rat hypothalamus-pituitary-adrenal system in vitro. II. Hypothalamus-pituitary cell-adrenal cell superfusion. Endocrinology 100:1153-1159
50. Silva CM, Powell-Oliver FE, Jewell CM, Sar M, Allgood VE, Cidlowski JA 1994 Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid. Steroids 59:436-442
51. Koch B, Lutz B, Briaud B, Mialhe C 1976 Heterogeneity of pituitary glucocorticoid binding evidence for a transcortin-like compound. Biochim Biophys Acta 444:497-507
52. De Kloet ER, Burbach P, Mulder GH 1977 Localization and role of transcortin-like molecules in the anterior pituitary. Mol Cell Endocrinol 7:261-273
53. Siiteri PK, Murai JT, Hammond GL, Nisker JA, Raymoure WJ, Kuhn RW 1982 The serum transport of steroid hormones. Recent Prog Horm Res 38:457-510
54. Ono N, Bedran de Castro JC, Mccann SM 1985 Ultrashort-loop positive feedback of corticotropin (ACTH)-releasing factor to enhance ACTH release in stress. Proc Natl Acad Sci USA 82:3528-3531
55. Fink G, Dow RC, Casley D, Johnston CI, Bennie J, Carroll S, Dick H 1992 Atrial natriuretic peptide is involved in the ACTH response to stress and glucocorticoid negative feedback in the rat. J Endocrinol 135:37-43
56. Franci CR, Anselmo-Franci JA, Mccann SM 1992 The role of endogenous atrial natriuretic peptide in resting and stress-induced release of corticotropin, prolactin, growth hormone, and thyroid-stimulating hormone. Proc Natl Acad Sci USA 89:11391-11395
57. Stec I, Barden N, Reul JMHM, Holsboer F 1994 Dexamethasone nonsuppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor. J Psychiatr Res 28:1-5
58. Carroll BJ, Martin FIR, Davies B 1968 Resistance to suppression by dexamethasone of plasma 11-O.H.C.S. levels in severe depressive illness. Br Med J 3:285-287
59. Von Bardeleben U, Holsboer F 1989 Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression. J Neuroendocrinol 1:485-488
60. Sachar EJ, Hellman L, Roffwarg HP, Halpern FS, Fukushima DK, Gallagher TF 1973 Disrupted 24-hr patterns of cortisol secretion in psychotic depression. Arch Gen Psychiatry 28:19-24
61. Linkowski P, Mendlewicz J, Leclercq R, Brasseur M, Hubain P, Golstein J, Copinschi G, Van Cauter E 1985 The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J Clin Endocrinol Metab 61:429-438
62. Holsboer F, Von Bardeleben U, Gerken A, Stalla GK, Müller OA 1984 Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. New Engl J Med 311:1127
63. Amsterdam JD, Maislin G, Berwish N, Phillips J, Winokur A 1989 Enhanced adrenocortical sensitivity to submaximal doses of cosyntropin (Alpha-1-24-corticotropin) in depressed patients. Arch Gen Psychiatry 46:550-554
64. Chrousos GP, Detera-Wadleigh SD, Karl M 1993 Syndromes of glucocorticoid resistance. Ann Int Med 119:1113-1124
65. Hurley DM, Accili D, Stratakis CA, Karl M, Vamvakopoulos N, Rorer E, Constantine K, Taylor SI, Chrousos GP 1991 Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest 87:680-686
66. Karl M, Lamberts SWJ, Deterawadleigh SD, Encio IJ, Stratakis CA, Hurley DM, Accili D, Chrousos GP 1993 Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene. J Clin Endocrinol Metab 76:683-689